Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308275 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Sana Khan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Cough, Patient Satisfaction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Canada.
Abstract (Originalsprache)
Background
Chronic cough (persisting for ≥8 weeks) is a common disorder affecting approximately 5 to 10% of adults worldwide that is sometimes refractory to treatment (refractory chronic cough [RCC]) or has no identifiable cause (unexplained chronic cough [UCC]). There is minimal information on the patient’s experience of RCC/UCC in Canada. The aim of this study was to evaluate the patient journey and perceptions related to RCC/UCC management in Canada.
Methods
Our exploratory study included Canadians in the Leger Opinion Panel and focused on individuals with RCC or UCC. Key entry criteria were: age ≥18 years, cough on most days for ≥8 weeks, no smoking within 1 year, no serious respiratory disease or lung cancer, and not taking angiotensin-converting enzyme inhibitors. Individuals who met entry criteria were invited to complete an approximately 30-minute online survey with questions on demographic characteristics, healthcare professional (HCP) interactions, diagnosis of underlying conditions, current treatments, and satisfaction with HCPs and chronic cough therapies.
Results
A total of 49,076 individuals completed the chronic cough screening questionnaire (July 30, 2021 to September 1, 2021): 1,620 (3.3%) met entry criteria for RCC or UCC, and 1,046 (2.1%) completed the online survey (mean age of 45 years, 61% female). Most respondents (58%) reported their chronic cough was managed by a general practitioner (GP). Forty-four percent of respondents did not have a diagnosis of an underlying condition for their cough. Breathing tests (39%) and chest imaging (34%) were the most common diagnostic tests. Cough suppressants (18%) were the most frequent current treatment. Respondents were moderately satisfied with their HCPs, but more than half considered their treatment ineffective and 34% had considered no longer seeking medical attention because of a lack of treatment success.
Conclusions
Individuals with RCC/UCC in Canada are largely unsatisfied with the effectiveness of treatment. Additional HCP education and new treatment options are needed to improve patient satisfaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, Ontario, Canada.
- Medical Affairs, Merck Canada Inc., Kirkland, Quebec, Canada.
- Medical Department, MSD, Madrid, Spain.
ORCID-Profile: Samuel Laventure, Imran Satia
Förderung
- Merck Canada
Zitieren
APA
Khan, S., Brister, D., Abraham, T., Laventure, S., Sahakian, S., Juliá, B., & Satia, I. (2024). Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey. PLOS ONE. https://doi.org/10.1371/journal.pone.0308275
Vancouver
Khan S, Brister D, Abraham T, Laventure S, Sahakian S, Juliá B, et al. Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey. PLOS ONE. 2024. doi:10.1371/journal.pone.0308275
BibTeX
@article{Khan2024,
author = {Khan, Sana and Brister, Danica and Abraham, Ted and Laventure, Samuel and Sahakian, Sevag and Juliá, Berta and Satia, Imran},
title = {Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308275}
}
EUVIMED